Is a complete BVMF/BLAU3 research report available?

Question

Accepted Answer

No complete published report is available for bvmf/BLAU3 (BVMF/BLAU3) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Market cap	2B
Revenue (ttm)	1.8B
Net income (ttm)	243.8M
EPS (ttm)	R$1.05
Shares out	231M
P/E (trailing)	8.2x
P/E (forward)	6.7x
Dividend	R$0.36 (4.13%)
Volume	752,800

Metric	Value
Country	Brazil
Country code	BR
Employees	1,900
Employees Change	600%
Employees Change Percent	46.15
Enterprise value	BRL 2B
Exchange	Brazil Stock Exchange
Financial currency	BRL
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	BRBLAUACNOR8
Last refreshed	2026-08-02
Market cap	BRL 2B
Price	BRL 8.6
Price currency	BRL
Rev Per Employee	928,607.89x
Sector	Healthcare
Sector PE	38.34
Sector PE Fwd	12.47
Sic	2836
Symbol	bvmf/BLAU3
Website	https://www.blau.com

Metric	Value
Earnings Yield	12.27%
EV Earnings	8.15x
EV/EBIT	6.03x
EV/EBITDA	5.13x
EV/FCF	61.14x
EV/Sales	1.13x
FCF yield	1.64%
Forward P/E	6.66x
P/B ratio	0.87x
P/E ratio	8.17x
P/S ratio	1.13x
PE Ratio3 Y	9.59x
PE Ratio5 Y	13.01x
PEG ratio	0.39x

Metric	Value
EBIT Margin	18.65%
EBITDA Margin	21.54%
FCF margin	1.84%
Gross margin	40.44%
Gross Profit	BRL 713.5M
Gross Profit Growth	3.62%
Gross Profit Growth Q	20.58%
Gross Profit Growth3 Y	5.15%
Gross Profit Growth5 Y	2.63%
Net Income	BRL 243.8M
Net Income Growth	-9.05%
Net Income Growth Q	-56.27%
Net Income Growth Years	1%
Net Income Growth3 Y	-11.68%
Net Income Growth5 Y	-4.64%
Pretax Margin	18.47%
Profit Margin	13.82%
Profit Per Employee	BRL 128,310
Profitable Quarters	BRL 37
Profitable Years	13
ROA	5.87
Roa5y	10.06
ROCE	11.4
ROE	10.86
Roe5y	18.51
ROIC	10.8
Roic5y	20.5

Metric	Value
Cagr1y	-2.96%
Cagr3y	-14.71%
Cagr5y	-23.6%
Div CAGR3	8.07%
EPS Growth	-8.75
EPS Growth Q	-56.67
EPS Growth Years	0
EPS Growth3 Y	-11.79
EPS Growth5 Y	-6.97
FCF Growth	-89.52%
FCF Growth Q	25.95%
FCF Growth3 Y	-27.95%
FCF Growth5 Y	-21.26%
OCF Growth	-39.4%
OCF Growth Q	-30.24%
OCF Growth3 Y	6.57%
OCF Growth5 Y	5.85%
Revenue Growth	-0.19x
Revenue Growth Q	16.62x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	9.29x
Revenue Growth5 Y	6.48x

BVMF/BLAU3 (BVMF/BLAU3)

Coverage state: Market snapshot only — no published research

Generate the first BVMF/BLAU3 analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · BVMF/BLAU3

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/BLAU3 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on BVMF/BLAU3

Frequently asked questions

Metric	Value
Asset Turnover	BRL 0.5
Assets	BRL 3.6B
Cash	BRL 542.2M
Current Assets	BRL 1.8B
Current Liabilities	BRL 687.8M
Debt	BRL 560.3M
Debt EBITDA	BRL 1.45
Debt Equity	BRL 0.25
Debt FCF	BRL 17.25
Equity	BRL 2.3B
Interest Coverage	4.18
Liabilities	BRL 1.3B
Long Term Assets	BRL 1.7B
Long Term Liabilities	BRL 610.8M
Net Cash	BRL -18.1M
Net Cash By Market Cap	BRL -0.91
Net Debt EBITDA	BRL 0.05
Net Debt Equity	BRL 0.01
Net Debt FCF	BRL 0.56
Tangible Book Value	BRL 2.1B
Tangible Book Value Per Share	BRL 8.98
WACC	7.29

Metric	Value
Current ratio	2.66
Inventory Turnover	1.54
Net Working Capital	BRL 847.9M
Quick ratio	1.67
Working Capital	BRL 1.1B
Working Capital Turnover	BRL 1.55

Metric	Value
Buyback Yield	0.33%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	BRL 0.36
Dividend Years	6
Dividend Yield	4.13%
Ex Div Date	2026-06-26
Last Dividend	BRL 0.08
Payout Frequency	Quarterly
Payout Ratio	25.73%

Metric	Value
1Y total return	-2.95%
200-day SMA	10.11
3Y total return	-37.96%
50-day SMA	9.92
50-day SMA vs 200-day SMA	50under200
5Y total return	-73.96%
All Time High	42.25
All Time High Change	-79.64%
All Time High Date	2021-07-19
All Time Low	7.08
All Time Low Change	21.52%
All Time Low Date	2024-06-20
ATR	0.34
Beta	0.39
Beta1y	0.69
Beta2y	0.53
Ch YTD	-20.43
High	8.76
High52	11.84
High52 Date	2026-04-17
High52ch	-27.36%
Low	8.35
Low52	8.35
Low52 Date	2026-07-31
Low52ch	2.99%
Ma50ch	-13.3%
Price vs 200-day SMA	-14.97%
RSI	27.08
RSI Monthly	38.93
RSI Weekly	39.04
Sharpe ratio	0.01x
Sortino ratio	0.16
Total Return	4.45%
Tr YTD	-19.22
Tr1m	-15.85%
Tr1w	-2.38%
Tr3m	-13.61%

Metric	Value
Analyst Count	12
Analyst Ratings	Hold
Operating Income	BRL 329.1M
Operating Income Growth	-14.84
Operating Income Growth Q	-22.87
Operating Income Growth3 Y	-5.76
Operating Income Growth5 Y	-5.85
Operating margin	18.65
Price target	BRL 12.26
Price Target Change	BRL 42.56

Metric	Value
Float	38,584,962%
Net Borrowing	10,780,000
Shares Insiders	83.3%
Shares Institutions	2.8%
Shares Out	230,984,961
Shares Qo Q	1.28%
Shares Yo Y	-0.33%

Metric	Value
Average Volume	269,690x
Bv Per Share	9.93
CAPEX	BRL -244.2M
Ch1m	-15.85
Ch1w	-2.38
Ch1y	-9.91
Ch3m	-14.26
Ch3y	-45.33
Ch5y	-78.29
Ch6m	-15.44
Change	-0.23%
Change From Open	-0.12
Close	8.62
Days Gap	-0.12
Depreciation Amortization	50,968,000
Dollar Volume	6,474,080
Earnings Date	2026-08-12
EBIT	BRL 329.1M
EBITDA	BRL 380.1M
EPS	BRL 1.05
F Score	6
FCF	BRL 32.5M
FCF EV Yield	1.64x
FCF Per Share	BRL 0.14
Financing CF	-131,790,000
Fiscal Year End	December
Founded	1,987
Goodwill	151,655,000
Graham Number	15.3381
Graham Upside	78.35
Income Tax	BRL 83.5M
Investing CF	-131,780,000
Is Primary Listing	1
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Last Split Date	2026-01-06
Last Split Type	Forward
Lynch Fair Value	BRL 5.26
Lynch Upside	-38.78
Ma150	10.21
Ma150ch	-15.74%
Ma20	9.46
Ma20ch	-9.11%
Net CF	9,786,000
Next Earnings Date	2026-08-12
Open	8.61
P FCF Ratio	61.15
P OCF Ratio	7.18
Payment Date	2026-07-07
Position In Range	60.98
Ppne	985,209,000
Price Date	2026-07-31
Price EBITDA	BRL 5.23
Ptbv Ratio	0.96
Relative Volume	3.15x
Revenue	1,764,355,000x
Tax By Revenue	4.73x
Tax Rate	25.62%
Tr6m	-14.15%
Volume	752,800
Z Score	2.51